Veenhuizen R B, Ruevekamp-Helmers M C, Helmerhorst T J, Kenemans P, Mooi W J, Marijnissen J P, Stewart F A
Division of Experimental Therapy, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Huis, Amsterdam.
Int J Cancer. 1994 Dec 15;59(6):830-6. doi: 10.1002/ijc.2910590620.
Toxicity studies for intraperitoneal photodynamic therapy (IPPDT) were performed in Wag/RijA rats, using specially designed light delivery blocks for proper light distribution and light dosimetry. A recently developed photosensitizer mesotetrahydroxyphenylchlorin (mTHPC), excited at 652-nm wave-length, was compared with Photofrin (630 nm). Toxicity profiles for various sensitizer doses, light fluences and time intervals were investigated. A light fluence of 15 J.cm-2 delivered to the entire peritoneum 24 hr after 5 mg Photofrin per kg i.v. induced reversible impairment of intestinal, liver and kidney function. A dose of 0.2 mg mTHPC per kg i.v. followed by 6 J.cm-2 at 72 hr appeared to be equitoxic to the intestines; however, functional tests revealed little effect for this mTHPC-mediated IPPDT regime on liver or kidney. Histology demonstrated focal irreversible damage to the kidneys for both photosensitizers, not reflected in functional impairment. Light doses of 25 to 30 J.cm-2 at 24 hr after Photofrin or 8-12 J.cm-2, 72 hr after mTHPC caused lethal toxicity in the first 2 weeks due to intestinal damage. Higher light doses caused a shock syndrome and rhabdomyolysis resulting in death within 20 hr for both photosensitizers. In conclusion, maximum tolerable schedules for whole-abdomen IPPDT were defined for Photofrin and mTHPC. Both photosensitizers caused similar toxicity profiles depending on drug dose, light fluence and time interval.
在Wag/RijA大鼠身上进行了腹腔内光动力疗法(IPPDT)的毒性研究,使用专门设计的光传输模块以实现适当的光分布和光剂量测定。将一种最近研发的、在652纳米波长下激发的光敏剂间四羟基苯基氯卟啉(mTHPC)与血卟啉衍生物(630纳米)进行了比较。研究了不同敏化剂剂量、光通量和时间间隔的毒性特征。静脉注射每千克5毫克血卟啉衍生物后24小时,向整个腹膜输送15焦/平方厘米的光通量会导致肠道、肝脏和肾脏功能出现可逆性损害。静脉注射每千克0.2毫克mTHPC,然后在72小时时给予6焦/平方厘米的光通量,对肠道似乎具有同等毒性;然而,功能测试显示这种mTHPC介导的IPPDT方案对肝脏或肾脏几乎没有影响。组织学检查表明,两种光敏剂都会对肾脏造成局灶性不可逆损伤,但这并未在功能损害中体现出来。血卟啉衍生物给药后24小时给予25至30焦/平方厘米的光剂量,或mTHPC给药后72小时给予8 - 12焦/平方厘米的光剂量,会在最初两周内由于肠道损伤导致致命毒性。更高的光剂量会引发休克综合征和横纹肌溶解,导致两种光敏剂在20小时内死亡。总之,确定了血卟啉衍生物和mTHPC全腹IPPDT的最大耐受方案。两种光敏剂根据药物剂量、光通量和时间间隔会产生相似的毒性特征。